NORTH
CHICAGO, Ill., June 22, 2017 /PRNewswire/
-- The board of directors of AbbVie Inc. (NYSE: ABBV) declared
a quarterly cash dividend of $0.64
per share.
The cash dividend is payable Aug.
15, 2017 to stockholders of record at the close of business
on July 14,
2017.
Since the company's inception in 2013, AbbVie has
increased its dividend by 60 percent. AbbVie is a member of
the S&P Dividend Aristocrats Index, which tracks companies that
have annually increased their dividend for at least 25 consecutive
years.
About AbbVie
AbbVie is a global, research-driven biopharmaceutical company
committed to developing innovative advanced therapies for some of
the world's most complex and critical conditions. The company's
mission is to use its expertise, dedicated people and unique
approach to innovation to markedly improve treatments across four
primary therapeutic areas: immunology, oncology, virology and
neuroscience. In more than 75 countries, AbbVie employees are
working every day to advance health solutions for people around the
world. For more information about AbbVie, please visit us at
www.abbvie.com. Follow @abbvie on Twitter
or view careers on our
Facebook or LinkedIn
page.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-300478620.html
SOURCE AbbVie